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EDITOR: The article by Prem Senthil et al.
1
offers valuable insights into the perspective
of patients when they have had a retinal
vein occlusion. Two points are worth making
that are pertinent to the subject, but not dis-
cussed by the authors. First, their results
suggest that patients who have had retinal
vein occlusion have different health con-
cerns to those with age-related macular
degeneration or diabetic eye disease. In our
experience, another difference is that retinal
vein occlusion is an unexpected event. Most
people with age-related macular degenera-
tion have heard of the condition, from the
press or friends, or at their ﬁrst attendance,
and most patients with diabetes already
know that their eyes may be affected. That
retinal vein occlusions occur with no warn-
ing may therefore lead to a different psy-
chological impact.
Second, the authors cite a participant
(interview 17) who said that injections
‘stopped the bleeding’, and this reﬂects our
impression that patients with retinal vein
occlusion have a poor understanding of the
nature of their condition or its manage-
ment. We carried out a pilot prospective
study (presented at the Irish College of Oph-
thalmologists Annual Conference 2017)
interviewing 20 consecutive retinal vein
occlusion clinic patients: three were new
and 17 were review patients. The median
age was 70.5 years (range 38–88 years).
Themes were identiﬁed by two authors, and
subsequently grouped and reﬁned after
discussion.
In response to the question, ‘You have
been diagnosed with a retinal vein occlu-
sion. What do you want to know about your
eye condition, but don’t know or understand
at present?’, several themes emerged. First,
concern was expressed about the cause of
the retinal vein occlusion, speciﬁcally in one
case that the condition may be cancerous
(‘…rogue vessels’), or that it was age-related
macular degeneration (because other
patients in the waiting area had this condi-
tion). A second theme was on prognosis
relating to speciﬁc activities: ‘…worried I
wouldn’t be able to read or drive’, as well as
concerns about occupation – a carpenter,
for example, asking ‘Can I do this?’. A third
theme related to aspects of treatment.
Patients wanted to know about alternatives:
‘Should I get glasses?’, and ‘…will an opera-
tion help?’. There was a desire to know
about treatment effectiveness: ‘Would it
have been worse if I didn’t get injections?’.
Treatment duration was also of interest to
patients: ‘…will there be an end to it?’.
Our study lacked the rigour of that of
Prem Senthil et al.1 However, comments
made by the patients revealed a variety of
messages that they have picked up on,
including speciﬁc incorrect misunderstand-
ings and a general uncertainty about treat-
ment. The comments also shone a light on
the outcomes that really matter to patients,
which are not visual acuity or anatomical
parameters.
It is our responsibility as health care pro-
fessionals to address the patient-centered
perspective highlighted by this work and by
Prem Senthil et al.1 This is worth doing, as
patients with a poor understanding of their
retinal vein occlusion may have unjustiﬁed
anxieties. More work is needed to deter-
mine if better understanding leads to
improved patient-related outcomes in reti-
nal vein occlusion.
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